We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MRL Changes Name to Focus Technologies

By HospiMedica staff writers
Posted on 17 May 2001
MRL Diagnostics (Herndon, VA, USA) has changed its name to Focus Technologies, Inc. The company began as a reference laboratory performing esoteric microbiology testing for other laboratories and has grown to become a global leader in infectious disease products and services, serving the international healthcare community from its European base in Hilversum, The Netherlands.

An ISO 9001 certified company, Focus Technologies manufactures and distributes diagnostics test kits for rare and emerging diseases and is the developer of The Surveillance Network (TSN), the global antimicrobial surveillance database. Within the anti-infective pharmaceutical market, Focus has become established as a premier research partner. The new name, says the company, was chosen as part of a strategic move to unite its different business strengths in one entity.

"We have expanded our capabilities over the course of more than two decades. The company needed a name that truly reflects all aspects of our business and our commitment to technology,” said Laurence R. McCarthy, Ph.D., president and CEO of Focus Technologies.




Related Links:
Focus Technologies

Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests